Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Project Outlier | Contract Pharma

What are you searching for?

Sign in

Search by

Project Outlier

Company Headquarters

1130 Camino Del Mar Suite E, Del Mar, CA, 92014, US

Driving Directions Phone: View Phone
View website

Request more information from Project Outlier

Request more information from Project Outlier

Categories from Project Outlier

Consulting, Process Excellence
Consulting, Six Sigma
Database Systems
Electronic Data Management
Enterprise Resource Planning
IT, Data Collection
IT, LIMS
IT, Outsourcing Services
IT, Process Automation
Process Development/Scale-Up Services
Process R&D
Project Management
System Integration
Training
Validation, Services

Related Content

Online Exclusives

Inside CPHI Milan’s New Sustainability Summit

Silvia Forroova shares how CPHI Milan’s new Sustainability Summit will bring pharma leaders together to tackle key sustainability challenges.

By: Charlie Sternberg

Breaking News

Contract Pharma Announces New Bio Outsourcing Conference in Cambridge

Two-day event will bring the biopharma outsourcing community together April 1-2, 2027.

By: Tim Wright

Breaking News

Astoriom Acquires Roylance Stability Storage and Roylance Scientific

Acquisition expands Astoriom’s specialist sample storage and biorepository capabilities in the UK.

By: Charlie Sternberg

Breaking News

James Alexander Corporation Becomes 100% Employee-Owned

The packaging solutions manufacturer has expanded its ESOP, giving employees full ownership of the company.

By: Charlie Sternberg

Collaborations & Alliances

ExploRNA, Łukasiewicz Research Network Partner on GMP Manufacturing of Next-Gen mRNA Cap Analogs

Łukasiewicz, known for advanced chemical synthesis and production scaling capabilities, will help ExploRNA ramp up its mRNA manufacturing.

By: Patrick Lavery

Breaking News

Sanner Rebrands Gilero, Expands Chicago Facility

North American expansion strengthens CDMO support for medtech and healthcare packaging.

By: Charlie Sternberg

Breaking News

Lilly Breaks Ground on $6.5B Houston Manufacturing Site

The new Texas facility will produce Lilly’s oral GLP-1 medicine Foundayo and other small-molecule therapies.

By: Charlie Sternberg

Breaking News

FDA Approves IntraBio’s Aqneursa as First Treatment for Ataxia-Telangiectasia

It is the second FDA-approved indication for Aqneursa, following Niemann-Pick disease type C.

By: Patrick Lavery

Promotions & Moves

Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer

Myers comes from OrsoBio, where he was Chief Medical Officer as well as Head of Development.

By: Patrick Lavery

Promotions & Moves

Codis Promotes Steven Facer to Chief Commercial Officer

Facer offers 30+ years of leadership experience across pharmaceuticals, medical devices, and packaging.

By: Charlie Sternberg

Breaking News

WuXi XDC Secures GMP Release for Singapore Manufacturing Site

The designation applies to the site’s BCM3 antibody intermediate and conjugated drug substance dual-function production line, and DP4 facility.

By: Patrick Lavery

Breaking News

Telix to Buy ITM in $1.65B Radiopharma Deal

The acquisition adds isotope production, manufacturing, and late-stage therapeutic assets to Telix’s radiopharmaceutical platform.

By: Charlie Sternberg

Breaking News

Made Scientific Acquires Cell Therapy Facility From National Resilience

The 85,000-sq.-ft. East Norriton site adds GMP cleanrooms, fill-finish capacity, and immediate onboarding for cell therapy sponsors.

By: Charlie Sternberg

Breaking News

Novo Nordisk to Acquire Three Obesity Drug Programs from Kallyope

Deal adds non-incretin obesity assets, including IND-ready peptide candidate K-554, as Novo seeks to broaden its metabolic pipeline.

By: Charlie Sternberg

Collaborations & Alliances

Bespak and Upperton Partner on Nasal Drug Delivery

The CDMO collaboration will combine Bespak’s nasal device portfolio with Upperton’s formulation, analytical and clinical manufacturing expertise.

By: Charlie Sternberg